VITIS

Vitis Pharma is a specialized pharmaceutical company based in Poland that focuses on the marketing and distribution of high-quality dietary supplements, medical devices, and probiotics. The company is best known for its leadership in the Polish pediatric market, particularly through its flagship probiotic brand, Dicoflor (Lactobacillus rhamnosus GG). Vitis Pharma's portfolio also includes products for infant colic, respiratory health, and immunity. In 2017, the company was acquired by the international pharmaceutical group Recordati, which integrated Vitis Pharma's operations to strengthen its presence in the Central and Eastern European consumer healthcare markets.